Jan H. Verheijen - Concepedia

Author

Jan H. Verheijen

Also Known As

J H Verheijen, J VERHEIJEN, J Verheijen, J. H. VERHEIJEN, J. H. Verheijen, J. Verheijen, J.H Verheijen, J.H. Verheijen, JAN VERHEIJEN, JH Verheijen

140

Publications

Citations

H-Index

135

Concepts

All Affiliations

Leiden University Leiden University Medical Center Netherlands Organisation for Applied Scientific Research Netherlands Heart Institute Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Jan H. Verheijen is an author at Leiden University specializing in medicine, pathology, and extracellular matrix.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	51	3.9K
2	Natural Sciences	8	8	724
3	Health Sciences	6	6	491
4	Engineering	4	4	284
5	Public Health	1	1	11

Jan H. Verheijen

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma Jan H. Verheijen, Erik Mullaart, G T G Chang, Thrombosis and Haemostasis Biomedical EngineeringProtein PurificationBioanalysisAnalytical ChemistryClinical Chemistry	1982	476
Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma Jan H. Verheijen, G T G Chang, Cornelis Kluft Thrombosis and Haemostasis Euglobulin FractionsImmunologyBlood CellPathologyPharmacotherapy	1984	340
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma Cornelis Kluft, Jan H. Verheijen, A.F.H. Jie, Scandinavian Journal of Clinical and Laboratory Investigation	1985	308
Matrix Metalloproteinase 2 Is Associated With Stable and Matrix Metalloproteinases 8 and 9 With Vulnerable Carotid Atherosclerotic Lesions Joost P. G. Sluijter, Wilco P. Pulskens, Arjan H. Schoneveld, Stroke	2005	196
Daytime Fluctuations in Blood of Tissue-Type Plasminogen Activator (t-PA) and Its Fast-Acting Inhibitor (PAI-1) Cornelis Kluft, A F H Jie, D C Rijken, Thrombosis and Haemostasis	1988	185
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. S Ganesh, Cornelis F.M. Sier, G Griffioen, PubMed UrologyColorectal Cancer InvasionPlasminogen ActivatorsGastrointestinal OncologyMedicine	1994	161
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin. Jan H. Verheijen, Martien P. M. Caspers, G T G Chang, The EMBO Journal MechanobiologySignal TransductionEngineeringMedicineFibrinolysis	1986	156
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Paul H.A. Quax, G N van Muijen, E J Weening-Verhoeff, The Journal of Cell Biology PathologyPlasmin-dependent WayCancer BiologyCellular PhysiologyTumor Biology	1991	156
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. T. J. de Vries, Paul H.A. Quax, M. Denijn, PubMed	1994	149
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. Paul H.A. Quax, C.M. van den Hoogen, Jan H. Verheijen, Journal of Biological Chemistry	1990	148

Page 1